NCT06200987

Brief Summary

To investigate if post-operative penile vibration stimulation kan be used to reduce or prevent sexual dysfunction and urinary incontinence after radical prostatectomy. This will be done in a randomized, controlled, non-blinded study. Men that undergo nerve preserving surgery for prostate cancer is allocated into an intervention group and a control group. A total of 100 men will be included for a power of 80%. The intervention group will be instructed to use the "Ferticare 2.0" vibrator for at least five minutes a day with an amplitude of 1 mm and frequency of 90 Hz (these settings were found in a pilot study) for a total of 9 months. Both groups will do the standard pelvic floor training program and both groups will be offered regular phosphodiesterase-5-inhibitor treatment. Before surgery, 3, 6 and 10 months after the patients will have to fill out four different questionnaires regarding sexual and urinary function, including IIEF-EF, EHS, "neglected side effects" and ICIQ-SF. (10 months is due to a wash-out period of 1 month after the intervention). The collected data will be analysed and the primary goal is to see if there is a significant difference in average spontaneous IIEF-EF score in the two groups 10 months after the surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Feb 2024Oct 2026

First Submitted

Initial submission to the registry

December 29, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 11, 2024

Completed
21 days until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

2.1 years

First QC Date

December 29, 2023

Last Update Submit

March 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Erectile function

    The erectile function compared to controls measured by IIEF-EF

    10 months

Secondary Outcomes (6)

  • ICIQ-UI-SF: The International Consultation on Incontinence Questionnaire - Urinary Incontinence - short form

    10 months

  • IIEF-EF score (The International Index of Erectile Function - Erectile Function)

    10 months

  • Diaper weighing test

    10 months

  • IIEF-EF (The International Index of Erectile Function - Erectile Function) over 25

    10 months

  • EHS (Erection Hardness Scale)

    10 months

  • +1 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The group randomized to use the vibrator for 9 months

Device: Penile vibrator

Controls

NO INTERVENTION

Usual standard treatment

Interventions

In addition to standard treatment with PDE5-inhibitors the intervention is daily stimulation for five minutes with the vibrator for 9 months

Intervention

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men who are undergoing nerve-sparing radical prostatectomy
  • Pre operative erectile function of IIEF-EF \> 25
  • Sexually active . Continent before surgery defined as a score of 0 on the ICIQ-SF questionnaire

You may not qualify if:

  • Urinary incontinent before surgery
  • Comorbidity that prevents the patient from taking PDE5-inhibitors
  • Disease in the penis or in the penile skin (Peyronies, phimosis)
  • Problems using the vibrator ie impaired function of the hands

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herlev and Gentofte Hospital

Herlev, 2730, Denmark

RECRUITING

Study Officials

  • Mikkel Fode, MD, PhD

    Department of Urology, Herlev and Gentofte University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Helene R Andersen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD fellow

Study Record Dates

First Submitted

December 29, 2023

First Posted

January 11, 2024

Study Start

February 1, 2024

Primary Completion

March 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

March 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Available upon request. Subject to approval from the Danish Data Protection Agency.

Shared Documents
STUDY PROTOCOL, SAP

Locations